Kate Tsirtsonis

804 total citations · 1 hit paper
6 papers, 618 citations indexed

About

Kate Tsirtsonis is a scholar working on Surgery, Pharmacology and Economics and Econometrics. According to data from OpenAlex, Kate Tsirtsonis has authored 6 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 2 papers in Pharmacology and 2 papers in Economics and Econometrics. Recurrent topics in Kate Tsirtsonis's work include Cancer, Lipids, and Metabolism (2 papers), Apelin-related biomedical research (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Kate Tsirtsonis is often cited by papers focused on Cancer, Lipids, and Metabolism (2 papers), Apelin-related biomedical research (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Kate Tsirtsonis collaborates with scholars based in United States, United Kingdom and France. Kate Tsirtsonis's co-authors include Michael J. Koren, Phillip D. Toth, Maria Laura Monsalvo, Eli M. Roth, Lesley Burgess, Christie M. Ballantyne, Evan A. Stein, Robert C. Scott, Michael Lillestol and R Češka and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and Kidney International.

In The Last Decade

Kate Tsirtsonis

5 papers receiving 606 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia

2014 553 citations Dirk Blom, Tomas Hala et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kate Tsirtsonis United States	5	512	227	128	95	78	6	618
Ioanna Gouni-Berthold Germany	4	358 0.7×	155 0.7×	108 0.8×	89 0.9×	49 0.6×	6	599
Marc Ditmarsch United States	11	451 0.9×	90 0.4×	245 1.9×	31 0.3×	119 1.5×	41	554
Tomas Hala United States	7	499 1.0×	249 1.1×	119 0.9×	176 1.9×	77 1.0×	9	672
Yong-Un Kim United States	6	328 0.6×	94 0.4×	87 0.7×	49 0.5×	51 0.7×	7	370
Marion Cousins Canada	10	497 1.0×	104 0.5×	126 1.0×	75 0.8×	116 1.5×	11	608
Bei Wang China	8	515 1.0×	153 0.7×	102 0.8×	95 1.0×	67 0.9×	26	631
Paula Robinson United States	4	526 1.0×	128 0.6×	223 1.7×	64 0.7×	168 2.2×	6	679
Patric Nelson United States	7	734 1.4×	310 1.4×	317 2.5×	92 1.0×	91 1.2×	9	868
TJ Smilde Netherlands	3	488 1.0×	121 0.5×	208 1.6×	80 0.8×	162 2.1×	5	755
Yong‐Joon Lee South Korea	10	357 0.7×	118 0.5×	92 0.7×	26 0.3×	58 0.7×	43	464

Countries citing papers authored by Kate Tsirtsonis

Since Specialization

Citations

This map shows the geographic impact of Kate Tsirtsonis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Tsirtsonis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Tsirtsonis more than expected).

Fields of papers citing papers by Kate Tsirtsonis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate Tsirtsonis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Tsirtsonis. The network helps show where Kate Tsirtsonis may publish in the future.

Co-authorship network of co-authors of Kate Tsirtsonis

This figure shows the co-authorship network connecting the top 25 collaborators of Kate Tsirtsonis. A scholar is included among the top collaborators of Kate Tsirtsonis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate Tsirtsonis. Kate Tsirtsonis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Winkle, Peter, Steven R. Goldsmith, Michael J. Koren, et al.. (2022). A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients. Cardiovascular Drugs and Therapy. 37(4). 743–755. 16 indexed citations

2.

Palin, Victoria, Tjeerd van Staa, Stephanie Steels, et al.. (2022). A first step towards best practice recommendations for the design and statistical analyses of pragmatic clinical trials: A modified Delphi approach. British Journal of Clinical Pharmacology. 88(12). 5183–5201. 4 indexed citations

3.

Hellawell, Jennifer, et al.. (2020). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of Amg 986, a Novel Small Molecule Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients. Journal of Cardiac Failure. 26(10). S68–S68. 7 indexed citations

4.

Floege, Jürgen, et al.. (2018). Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial. Kidney International. 93(6). 1475–1482. 38 indexed citations

5.

Blom, Dirk, Maria Laura Monsalvo, Kate Tsirtsonis, et al.. (2015). EFFECTS OF EVOLOCUMAB (AMG 145) TREATMENT ON VITAMIN E LEVELS: RESULTS FROM THE 52-WEEK PHASE 3 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED DESCARTES STUDY. Journal of the American College of Cardiology. 65(10). A1367–A1367.

6.

Blom, Dirk, Tomas Hala, Michael A. Bolognese, et al.. (2014). A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia. New England Journal of Medicine. 370(19). 1809–1819. 553 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact